Trident Resources Announces the Acquisition of Claims from Eagle Plains Resources Within the La Ronge Gold Belt in Saskatchewan, Canada

(TSX-V:ROCK),(OTC US:TRDTF),(OTCQB:TRDTF), Vancouver, BC, Aug. 12, 2025 (GLOBE NEWSWIRE) — Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company“) is pleased to announce that it has signed a non-arm's length agreement (the “Agreement“) with Eagle Plains Resources Ltd. (“Eagle Plains” or “EPL“) pursuant to which the Company has acquired a 100% interest in […]

Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates

(NASDAQ:KRRO), — Interim readout from Phase 1/2a REWRITE clinical trial of KRRO-110 on track for the second half of 2025 — Completed dosing of over 80% of planned REWRITE healthy volunteers across multiple single ascending dose (SAD) cohorts with no treatment emergent serious adverse events (SAEs) or dose limiting toxicities observed — European Medicines Agency

Gain Therapeutics Reports Financial Results for Second Quarter 2025 and Provides Corporate Update

(NasdaqGM:GANX), Reached full enrolment of Phase 1b study evaluating GT-02287 in Parkinson's Disease (PD) with or without GBA1 mutations during 2Q 2025, earlier than anticipated Analysis of functional changes and biomarker activity at 90 days will be available during 4Q 2025 In July 2025 following the close of 2Q 2025, Gain completed an underwritten public

Hydrofarm Holdings Group Announces Second Quarter 2025 Results

(NASDAQ:HYFM), SHOEMAKERSVILLE, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture, today announced financial results for its second quarter ended June 30, 2025. Second Quarter Highlights vs. Prior Year Period: Net

FarmQA Adds Advanced Prescriptions & Nutrient Blender for Faster, Smarter Fertility Plans

Two new tools help agronomists spend less time on math and more time with growers FarmQA has launched two new agronomy tools that significantly reduce the time it takes to create nutrient plans. Advanced Prescriptions enables fast, formula-based variable rate recommendations, while Nutrient Blender delivers quick, flat-rate fertility planning. Together, they give agronomists more ways

Bitfarms Reports Second Quarter 2025 Results

(TSX:BITF),(NasdaqGM:BITF), Executing HPC/AI Growth Strategy with Industry-Leading Strategic Partners & Robust Balance Sheet – Revenue of $78 million, up 87% Y/Y –– Gross mining margin of 45%, down from 51% in Q2 2024 – – Master Site Plan for Panther Creek, PA data center campus submitted to Macquarie –– Partnered with data center builder and

Tecnoglass to Attend the Raymond James Industrial Showcase

(NYSE:TGLS), Miami, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NYSE: TGLS) (“Tecnoglass” or the “Company”), a leading producer of high-end aluminum and vinyl windows and architectural glass for the global residential and commercial end markets, today announced that the Company will attend the virtual Raymond James Industrial Showcase on Thursday, August 14, 2025.

Hixny Makes Healthcare Encounter Alerts Available Immediately to Providers Statewide Through the Statewide Health Information for New York

Hixny has been awarded a contract by the Statewide Health Information Network for New York (SHIN-NY) to make patient encounter alerts available to healthcare providers and health insurers statewide, effective immediately. The alerts system is the next iteration of an existing service that has proven reliable to thousands of Hixny's existing health information exchange (HIE)

OTC Markets Group Welcomes First Phosphate Corp. to OTCQX

(Other OTC:OTCM),(OTC US:OTCM),(CNSX:PHOS.CN),(Other OTC:FRSPF), NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced First Phosphate Corp. (CSE: PHOS; OTCQX: FRSPF), an igneous phosphate mineral development company for the LFP battery industry, has qualified to trade on the

Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights

(NASDAQ:ABOS), Expect to report topline results for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug (ACU193) for the treatment of early Alzheimer's disease, in late 2026 Expect decision to advance an oligomer-targeted Enhanced Brain DeliveryTM product candidate in early 2026 Cash, cash equivalents and marketable securities of $166.2 million as of June 30, 2025, expected

Scroll to Top